Editorial label review
Midi Health side effects: anxiety
Primary formulary: Estradiol (patch, pill, gel) + micronized progesterone; paroxetine 7.5 mg (Brisdelle); fezolinetant (Veozah)
Quick answer
Anxiety shows up on the FDA labels for the active ingredients Midi Health prescribes — Estradiol (patch, pill, gel) + micronized progesterone. This page walks through the labelled frequency ranges, what to watch for, and when to call your clinician.
What Midi Health prescribes and why it matters for anxiety
Midi Health prescribes FDA-approved estradiol and progesterone plus non-hormonal options — paroxetine 7.5 mg (Brisdelle) and fezolinetant (Veozah) — for patients who cannot or prefer not to use estrogen. Because Midi Health prescribes FDA-approved active ingredients, the labelled adverse-reaction tables from those medications describe the frequencies you should expect. Anxiety appears in estradiol, progesterone, and paroxetine (Brisdelle) label sections used by these brands.
Common label-level side effects
Sourced from Section 6 (Adverse Reactions) of each FDA-approved PIL.
- Anxiety and nervousness are listed at 1–5% in most estradiol PILs Section 6 adverse-reaction tables
- The Prometrium (progesterone) PIL Section 5.6 warns of mood changes including anxiety and irritability
- The Brisdelle (paroxetine 7.5 mg) PIL lists activation-syndrome features — nervousness, restlessness — at ~2–5%
Serious label-level warnings
Drawn from Section 5 (Warnings and Precautions) of the FDA-approved PILs — including the estradiol boxed warning where applicable.
- Paroxetine 7.5 mg carries the FDA class boxed warning for suicidal ideation in young adults — reassess urgently if new suicidal thoughts appear
- Estradiol PIL Section 5.1 flags any severe mood change alongside chest symptoms as a cardiovascular red flag
When to contact your clinician
Call your clinician if anxiety worsens sharply, sleep collapses, or you notice suicidal thoughts — the paroxetine PIL requires prompt reassessment of the risk-benefit balance.
Call 911 if you develop chest pain, one-sided weakness, sudden severe headache, vision or speech change, or shortness of breath — per the estradiol PIL boxed warning for cardiovascular events.
What to ask your provider
- “Which SKU in the Midi Health formulary am I on, and what is its labelled frequency for anxiety?”
- “Is my anxietylikely a labelled adverse reaction, or something separate that needs its own workup?”
- “Would a different delivery route (patch vs. pill, oral vs. transdermal) change my expected frequency?”
- “What is the plan if anxietydoes not settle within 2–3 cycles?”
Related editorial reading
- Full editorial review of Midi Health — formulary, pricing, and clinician model.
- Is anxiety caused by menopause itself? — how the transition presents on its own.
- Estradiol medication page — mechanism, dosing, and full PIL notes.
- Paroxetine low dose medication page — secondary ingredient in Midi Health's formulary.
- Browse all side-effect matrix pages — 4 brands × 15 symptoms.
Frequently asked questions
- How often does anxiety happen on Midi Health?
- Midi Health's primary regimen — Estradiol (patch, pill, gel) + micronized progesterone; paroxetine 7.5 mg (Brisdelle); fezolinetant (Veozah) — carries the FDA-labelled adverse-reaction frequencies for anxiety described on this page. Ranges vary from < 1% to 45% depending on the specific active ingredient and delivery route. See the sources block for the exact PIL tables.
- When should I stop Midi Health because of anxiety?
- Talk to your clinician immediately if you meet any of the "when to contact" criteria on this page — most estradiol PIL Section 5 warnings require prompt reassessment. Do not stop hormone therapy without medical input; abrupt discontinuation can trigger rebound symptoms.
- Is anxiety on the FDA label for Midi Health's medications?
- Anxiety appears in estradiol, progesterone, and paroxetine (Brisdelle) label sections used by these brands.
- Is anxiety caused by menopause itself?
- Anxiety can appear during the menopause transition for reasons unrelated to hormone therapy. Our /does-menopause-cause/anxiety explainer covers what the underlying biology is and how clinicians disentangle the transition from the treatment.
Sources
- FDAFDA-approved label — Estrace (estradiol) via DailyMed
- FDAFDA-approved label — Vivelle-Dot (estradiol transdermal) via DailyMed
- FDAFDA-approved label — Prometrium (micronized progesterone) via DailyMed
- FDAFDA-approved label — Brisdelle (paroxetine 7.5 mg) via DailyMed
- FDAFDA-approved label — Veozah (fezolinetant) via DailyMed